The experimental drug, called daraxonrasib, does not cure pancreatic cancer, which is one of the deadliest and most difficult-to-treat cancers, but it gives many patients the next best thing: more time.
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: Chicago Tribune (@chicagotribune.com)
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: Chicago Tribune (@chicagotribune.com)